European Innovation Council

Axelera AI focuses on providing specialized hardware and software platforms to enhance artificial intelligence tasks, particularly in edge computing. Its primary product, the Metis™ AI Platform, combines hardware and software to offer high-performance, energy-efficient AI inference solutions. The platform's innovative design has earned recognition as a CES® 2024 Innovation Awards Honoree. Established in 2021 after incubation by Bitfury and collaboration with imec, Axelera AI is headquartered in the AI Innovation Center at the High Tech Campus in Eindhoven, with research and development offices in Belgium, Switzerland, and Italy. The company's team comprises experts in AI from leading firms and Fortune 500 companies, focusing on delivering sustainable edge applications through a custom dataflow architecture and multicore in-memory computing that minimizes power consumption.

Nanogence SA, established in 2017 and located in Renens, Switzerland, specializes in the development of innovative material solutions for the construction industry. The company focuses on creating synthetic, tailor-made materials that enhance the performance and sustainability of construction applications, including cement and concrete. By leveraging advanced knowledge in chemistry, material science, and nanotechnology, Nanogence has developed patented additive formulations that significantly improve the binding efficiency of cement and concrete while reducing carbon emissions by up to 50%. This enables manufacturers to achieve valuable cost savings, enhance durability, and contribute to more sustainable construction practices in a rapidly growing global market.

Swisspod Technologies SA is a transport development firm based in Monthey, Switzerland, founded in 2019. The company focuses on designing and developing Hyperloop vessels, which are tube-based transportation systems aimed at providing sustainable and efficient high-speed travel. Swisspod leverages high-quality Swiss engineering to create fully-electric Hyperloop pods that promise scalable and rapid transit between distant cities. The firm emphasizes energy efficiency and economic viability in its innovations, making its capsules both affordable and environmentally friendly. With a team of multidisciplinary experts, Swisspod is dedicated to transforming high-speed travel through its cutting-edge technology.

Xeltis is a clinical-stage medical device company focused on transforming cardiovascular treatment through innovative restorative technologies. The company has developed advanced polymer-based devices, including bioabsorbable heart valves and implantable small diameter blood vessels, intended for hemodialysis vascular access and coronary artery bypass graft surgery. These devices leverage proprietary technology to facilitate endogenous tissue restoration, allowing the body to naturally regenerate the complex structures being replaced. Xeltis emerged from the merger of two university spin-offs from the Netherlands and Switzerland and operates in both the Netherlands and the USA. The company is backed by several venture capital firms and has secured significant funding from the European Investment Bank and the European Innovation Council Accelerator. Currently, Xeltis is conducting ongoing clinical trials to advance its restorative cardiovascular solutions.

EBAMed SA is a Swiss startup based in Geneva, established in 2018, that focuses on developing innovative medical technology for treating heart arrhythmias. The company is working on an ultrasound-based device designed to monitor heart motion and facilitate non-invasive ablation therapy using proton beams. This technology aims to provide a safe and effective alternative for patients by allowing real-time synchronization of proton therapy with heart movement. By integrating both hardware and software components, EBAMed's device enhances treatment capabilities for existing proton therapy centers, enabling them to offer advanced, non-invasive treatment options for cardiac patients in an outpatient setting.

TreaTech is a Swiss Cleantech company founded in 2015 by engineers from the École Polytechnique Fédérale de Lausanne (EPFL). The company focuses on developing innovative treatment technology aimed at addressing the challenges of wastewater management. Its catalytic hydrothermal gasification (HTG) system provides an eco-friendly solution for the disposal of various liquid wastes, such as sewage sludge, which are typically incinerated or sent to landfills. This advanced thermochemical process transforms these wastes into valuable by-products, including renewable gas, clean water, and mineral salts that can be further upgraded into fertilizers. TreaTech's approach aligns with sustainable development goals and the principles of a circular economy, enabling clients to benefit from efficient wastewater treatment while recycling essential resources.

Wingtra AG, founded in 2014 and based in Zürich, Switzerland, specializes in the manufacture of professional drones, notably the WingtraOne, a vertical take-off and landing (VTOL) UAV. This drone is designed for high-precision data collection and has applications across various industries, including surveying, agriculture, forestry, and infrastructure management. Since its market introduction in 2017, Wingtra has established partnerships with over 50 major surveying equipment dealers globally, facilitating the adoption of its technology. The WingtraOne can be operated using WingtraPilot software, enabling users to collect survey-grade aerial data that can be transformed into two-dimensional maps and three-dimensional models, thereby enhancing monitoring and inspection capabilities in sectors such as construction, mining, and environmental management.

Resistell AG, founded in 2018 and located in Muttenz, Switzerland, develops and markets a diagnostic device for antibiotic susceptibility testing. Utilizing nanomotion technology, the device detects the movement of living bacterial cells to assess their resistance to antibiotics, offering a rapid alternative to traditional culture-based methods. This innovative approach allows for timely and accurate identification of the most effective antibiotics for patients, addressing the growing challenge of antibiotic resistance.

ABCDx SA is a Swiss company founded in 2014 that specializes in the development, validation, and application of biomarker tests for brain injury treatment. The company focuses on creating biomarker panels designed to identify and diagnose patients at risk for severe long-term complications resulting from conditions such as traumatic brain injuries, strokes, and post-stroke infections. The founders are prominent researchers from the University of Geneva and the Vall d’Hebron Research Institute, bringing significant expertise in biomarker discovery and clinical application. They are complemented by a third founder with extensive experience in the diagnostic and pharmaceutical industries, enhancing the company’s capacity to innovate in brain health diagnostics.

ScanTrust SA is a Swiss company that specializes in a cloud-based IoT platform aimed at enhancing product and packaging security through unique identifiers. Founded in 2014 and with operations in cities such as Shanghai, Singapore, and Bangkok, ScanTrust provides a suite of tools including a printer portal for packaging partners to integrate secure codes into their processes, and Scan-data, an online portal for real-time business intelligence and supply chain insights. Additionally, the platform enables product authentication and supply chain traceability using QR codes, which can be verified through mobile applications. By protecting brands and facilitating consumer engagement, ScanTrust helps companies navigate the complexities of selling physical products in a connected market.

Positrigo AG is a Swiss company based in Zurich that specializes in the development, production, and sales of dedicated brain positron emission tomography (PET) scanners. Founded in 2018, Positrigo focuses on making functional brain imaging accessible for early detection of neurodegenerative diseases, particularly Alzheimer's disease. The company provides advanced scanning solutions that aid in diagnostics, treatment monitoring, and the development of new therapies for conditions such as Lewy body dementia, vascular dementia, and frontotemporal dementia. By enabling early diagnosis in an affordable manner, Positrigo aims to improve patient outcomes and support healthcare professionals in managing these complex medical conditions.

Vatorex AG, founded in 2016 and based in Winterthur, Switzerland, specializes in developing electronic solutions for beekeeping, specifically targeting the varroa mite, a significant threat to honey bee health. The company offers a range of products, including the Varroa Solution, a heat treatment system that effectively eliminates varroa mites while preserving the bees. Additionally, Vatorex provides the Full Hive Kit, which enables real-time monitoring and data collection for hive management, and the Hive Manager mobile application, designed for organizing hive-related information. By focusing on hyperthermic treatment that exploits the different temperature tolerances of bees and mites, Vatorex aims to enhance the health and sustainability of bee populations. The company markets its innovative solutions online, contributing to modern beekeeping practices.

ABCDx SA is a Swiss company founded in 2014 that specializes in the development, validation, and application of biomarker tests for brain injury treatment. The company focuses on creating biomarker panels designed to identify and diagnose patients at risk for severe long-term complications resulting from conditions such as traumatic brain injuries, strokes, and post-stroke infections. The founders are prominent researchers from the University of Geneva and the Vall d’Hebron Research Institute, bringing significant expertise in biomarker discovery and clinical application. They are complemented by a third founder with extensive experience in the diagnostic and pharmaceutical industries, enhancing the company’s capacity to innovate in brain health diagnostics.

Plair SA specializes in the development and manufacturing of advanced systems for monitoring environmental conditions, particularly focusing on airborne particles. Founded in 2014 and based in Geneva, Switzerland, the company offers a range of innovative instruments, including the Particle Analyzer PA-300, which provides real-time detection, identification, and classification of fine particles in the air. This device can differentiate various entities such as pollen species, organic particles like fungal spores, and pollutants including polycyclic aromatic hydrocarbons. Additionally, Plair SA's Rapid-E and Rapid-C instruments utilize cutting-edge technologies like laser-induced fluorescence and light scattering for comprehensive analysis of aerosol particles. The company's solutions cater to applications in airborne allergen monitoring, air quality assessment, and bioaerosol analysis, enabling a deeper understanding of atmospheric aerosol concentrations. Plair SA is a spin-off from the University of Geneva, reflecting its strong academic foundation.

Artiria Medical SA develops innovative micro-actuated devices aimed at treating vascular diseases, particularly in the brain. Founded in 2019 and based in Lausanne, Switzerland, the company focuses on enhancing the precision and control of surgical procedures involving catheters and guidewires. Its technology facilitates micromotion within brain arteries, thereby improving navigation during stroke treatments. By enabling surgeons to perform these complex procedures with greater accuracy, Artiria Medical contributes to better patient outcomes and the potential to save lives.

Oxara AG, founded in 2018 and based in Zurich, Switzerland, focuses on providing sustainable building materials to address challenges in the construction industry, such as resource scarcity and high CO2 emissions. The company specializes in cement-free admixtures and binder technology, offering products like Oxacrete, Oxaflow, Oxabrick, Cleancrete, Cleanflow, and Cleanbrick. Oxara's innovative approach utilizes locally available landfill waste to produce a poured earth concrete that retains the advantages of traditional concrete while being significantly more eco-friendly and cost-effective. The company aims to foster a global community dedicated to sustainable construction and affordable housing, prioritizing social responsibility and environmental stewardship in its operations.

Embotech, short for embedded optimization technologies, was founded in September 2013. They strive to lead the market for numerical optimization solutions that will be integral part of tomorrow's decision making systems. The company is a spin-off of the Automatic Control Laboratory from ETH Zurich.

OxyPrem AG is a Swiss company that specializes in developing and manufacturing sensor solutions for monitoring preterm infants. Founded in 2018 and based in Zurich, OxyPrem offers an advanced reusable oxygen sensor that continuously measures brain oxygen levels in high-risk preterm infants using noninvasive near-infrared light technology. This device accurately determines hemoglobin oxygen saturation in any human tissue, allowing healthcare providers to deliver improved clinical care while significantly reducing waste. By enabling real-time monitoring, OxyPrem's technology plays a crucial role in preventing early death and mitigating the risk of severe long-term brain damage in this vulnerable population.

Nagi Bioscience SA, based in Lausanne, Switzerland, specializes in the development and manufacturing of an innovative automated testing device that utilizes microscopic worms for substance testing in pharmaceutical, chemical, and cosmetic industries. Their flagship product, the Caenorhabditis elegans-on-chip, integrates the use of these organisms for in vivo testing with a fully automated platform for in vitro culture, treatment, and analysis. This technology facilitates comprehensive toxicity testing, drug discovery, and anthelmintic testing applications, allowing clients to evaluate biological responses observable only at the whole-organism level. Nagi Bioscience aims to transform traditional testing methodologies by introducing its unique "Organism-on-Chip" technology.

Qnami AG is a Swiss company established in 2017, specializing in the development of quantum sensing technologies for nanoscale imaging. The company manufactures non-invasive sensors, including the ProteusQ magnetic imaging microscope and the Quantum Diamond product line, which features diamond probes with single nitrogen-vacancy (NV) centers for high-resolution magnetic imaging. These advanced technologies enable the measurement of electric and magnetic fields with exceptional sensitivity, facilitating a range of applications such as the characterization of magnetic random-access memory (MRAM), imaging of proteins, and fundamental studies of superconductors. Qnami's innovations unlock new possibilities in both scientific research and industrial applications, aiming to enhance understanding and improve various aspects of life and technology.

Bloom Biorenewables Ltd is a Swiss company founded in 2019, focused on developing technology that transforms wood and agricultural waste into renewable materials as alternatives to petroleum. The company specializes in creating bio-based materials for the chemical industry, targeting various markets including fragrances, plastics, and textiles. By introducing innovative production methods for biorenewable products and fuels, Bloom Biorenewables aims to provide sustainable solutions that reduce reliance on fossil fuels and contribute to climate change mitigation.

Xeltis is a clinical-stage medical device company focused on transforming cardiovascular treatment through innovative restorative technologies. The company has developed advanced polymer-based devices, including bioabsorbable heart valves and implantable small diameter blood vessels, intended for hemodialysis vascular access and coronary artery bypass graft surgery. These devices leverage proprietary technology to facilitate endogenous tissue restoration, allowing the body to naturally regenerate the complex structures being replaced. Xeltis emerged from the merger of two university spin-offs from the Netherlands and Switzerland and operates in both the Netherlands and the USA. The company is backed by several venture capital firms and has secured significant funding from the European Investment Bank and the European Innovation Council Accelerator. Currently, Xeltis is conducting ongoing clinical trials to advance its restorative cardiovascular solutions.

Xeltis is a clinical-stage medical device company focused on transforming cardiovascular treatment through innovative restorative technologies. The company has developed advanced polymer-based devices, including bioabsorbable heart valves and implantable small diameter blood vessels, intended for hemodialysis vascular access and coronary artery bypass graft surgery. These devices leverage proprietary technology to facilitate endogenous tissue restoration, allowing the body to naturally regenerate the complex structures being replaced. Xeltis emerged from the merger of two university spin-offs from the Netherlands and Switzerland and operates in both the Netherlands and the USA. The company is backed by several venture capital firms and has secured significant funding from the European Investment Bank and the European Innovation Council Accelerator. Currently, Xeltis is conducting ongoing clinical trials to advance its restorative cardiovascular solutions.

SwissDeCode is a company based in Renens, Switzerland, that specializes in food safety and compliance services for food manufacturers. Founded in 2016, the company provides rapid onsite DNA testing solutions that help ensure food is safe to eat. By offering plug-and-play systems, SwissDeCode enables production facilities to obtain food safety and quality certificates within the same work shift. This capability allows food producers to swiftly address contamination threats and convert them into sustainable opportunities. Additionally, SwissDeCode's services verify food authenticity, safety, and origin, empowering inspectors to make immediate decisions regarding food compliance.

Positrigo AG is a Swiss company based in Zurich that specializes in the development, production, and sales of dedicated brain positron emission tomography (PET) scanners. Founded in 2018, Positrigo focuses on making functional brain imaging accessible for early detection of neurodegenerative diseases, particularly Alzheimer's disease. The company provides advanced scanning solutions that aid in diagnostics, treatment monitoring, and the development of new therapies for conditions such as Lewy body dementia, vascular dementia, and frontotemporal dementia. By enabling early diagnosis in an affordable manner, Positrigo aims to improve patient outcomes and support healthcare professionals in managing these complex medical conditions.

AgroSustain SA, founded in 2018 and based in Nyon, Switzerland, specializes in developing natural and organic solutions for plant protection, particularly against fungal pathogens that affect fruits and vegetables. The company creates biological fungicides and coatings using plant extracts to prevent the growth of harmful fungi, such as botrytis cinerea and fusarium oxysporum. By extending the shelf life of crops, AgroSustain aims to reduce food waste and support organic food production. Their innovative approach focuses on providing sustainable, farm-to-fork solutions that help farmers maintain the quality of their produce while minimizing reliance on synthetic chemicals.

UniSieve Ltd, founded in 2018 and headquartered in Zurich, Switzerland, develops and manufactures advanced molecular sieving membranes that enable efficient separation solutions across various industries. The company's innovative platform technology integrates molecular sieves with polymeric membranes to facilitate applications such as chemical feedstock purification, biogas upgrading, gas and liquid separation, and specialized uses in sensing and space-related projects. UniSieve's technology is designed to enhance energy efficiency in size-based purification processes, supporting clients in reducing carbon dioxide emissions, improving recycling rates, and lowering operational costs.

Wingtra AG, founded in 2014 and based in Zürich, Switzerland, specializes in the manufacture of professional drones, notably the WingtraOne, a vertical take-off and landing (VTOL) UAV. This drone is designed for high-precision data collection and has applications across various industries, including surveying, agriculture, forestry, and infrastructure management. Since its market introduction in 2017, Wingtra has established partnerships with over 50 major surveying equipment dealers globally, facilitating the adoption of its technology. The WingtraOne can be operated using WingtraPilot software, enabling users to collect survey-grade aerial data that can be transformed into two-dimensional maps and three-dimensional models, thereby enhancing monitoring and inspection capabilities in sectors such as construction, mining, and environmental management.

Wingtra AG, founded in 2014 and based in Zürich, Switzerland, specializes in the manufacture of professional drones, notably the WingtraOne, a vertical take-off and landing (VTOL) UAV. This drone is designed for high-precision data collection and has applications across various industries, including surveying, agriculture, forestry, and infrastructure management. Since its market introduction in 2017, Wingtra has established partnerships with over 50 major surveying equipment dealers globally, facilitating the adoption of its technology. The WingtraOne can be operated using WingtraPilot software, enabling users to collect survey-grade aerial data that can be transformed into two-dimensional maps and three-dimensional models, thereby enhancing monitoring and inspection capabilities in sectors such as construction, mining, and environmental management.

Vatorex AG, founded in 2016 and based in Winterthur, Switzerland, specializes in developing electronic solutions for beekeeping, specifically targeting the varroa mite, a significant threat to honey bee health. The company offers a range of products, including the Varroa Solution, a heat treatment system that effectively eliminates varroa mites while preserving the bees. Additionally, Vatorex provides the Full Hive Kit, which enables real-time monitoring and data collection for hive management, and the Hive Manager mobile application, designed for organizing hive-related information. By focusing on hyperthermic treatment that exploits the different temperature tolerances of bees and mites, Vatorex aims to enhance the health and sustainability of bee populations. The company markets its innovative solutions online, contributing to modern beekeeping practices.

SwissDeCode is a company based in Renens, Switzerland, that specializes in food safety and compliance services for food manufacturers. Founded in 2016, the company provides rapid onsite DNA testing solutions that help ensure food is safe to eat. By offering plug-and-play systems, SwissDeCode enables production facilities to obtain food safety and quality certificates within the same work shift. This capability allows food producers to swiftly address contamination threats and convert them into sustainable opportunities. Additionally, SwissDeCode's services verify food authenticity, safety, and origin, empowering inspectors to make immediate decisions regarding food compliance.

Positrigo AG is a Swiss company based in Zurich that specializes in the development, production, and sales of dedicated brain positron emission tomography (PET) scanners. Founded in 2018, Positrigo focuses on making functional brain imaging accessible for early detection of neurodegenerative diseases, particularly Alzheimer's disease. The company provides advanced scanning solutions that aid in diagnostics, treatment monitoring, and the development of new therapies for conditions such as Lewy body dementia, vascular dementia, and frontotemporal dementia. By enabling early diagnosis in an affordable manner, Positrigo aims to improve patient outcomes and support healthcare professionals in managing these complex medical conditions.

Positrigo AG is a Swiss company based in Zurich that specializes in the development, production, and sales of dedicated brain positron emission tomography (PET) scanners. Founded in 2018, Positrigo focuses on making functional brain imaging accessible for early detection of neurodegenerative diseases, particularly Alzheimer's disease. The company provides advanced scanning solutions that aid in diagnostics, treatment monitoring, and the development of new therapies for conditions such as Lewy body dementia, vascular dementia, and frontotemporal dementia. By enabling early diagnosis in an affordable manner, Positrigo aims to improve patient outcomes and support healthcare professionals in managing these complex medical conditions.

Resistell AG, founded in 2018 and located in Muttenz, Switzerland, develops and markets a diagnostic device for antibiotic susceptibility testing. Utilizing nanomotion technology, the device detects the movement of living bacterial cells to assess their resistance to antibiotics, offering a rapid alternative to traditional culture-based methods. This innovative approach allows for timely and accurate identification of the most effective antibiotics for patients, addressing the growing challenge of antibiotic resistance.

TreaTech is a Swiss Cleantech company founded in 2015 by engineers from the École Polytechnique Fédérale de Lausanne (EPFL). The company focuses on developing innovative treatment technology aimed at addressing the challenges of wastewater management. Its catalytic hydrothermal gasification (HTG) system provides an eco-friendly solution for the disposal of various liquid wastes, such as sewage sludge, which are typically incinerated or sent to landfills. This advanced thermochemical process transforms these wastes into valuable by-products, including renewable gas, clean water, and mineral salts that can be further upgraded into fertilizers. TreaTech's approach aligns with sustainable development goals and the principles of a circular economy, enabling clients to benefit from efficient wastewater treatment while recycling essential resources.

TreaTech is a Swiss Cleantech company founded in 2015 by engineers from the École Polytechnique Fédérale de Lausanne (EPFL). The company focuses on developing innovative treatment technology aimed at addressing the challenges of wastewater management. Its catalytic hydrothermal gasification (HTG) system provides an eco-friendly solution for the disposal of various liquid wastes, such as sewage sludge, which are typically incinerated or sent to landfills. This advanced thermochemical process transforms these wastes into valuable by-products, including renewable gas, clean water, and mineral salts that can be further upgraded into fertilizers. TreaTech's approach aligns with sustainable development goals and the principles of a circular economy, enabling clients to benefit from efficient wastewater treatment while recycling essential resources.

Nanogence SA, established in 2017 and located in Renens, Switzerland, specializes in the development of innovative material solutions for the construction industry. The company focuses on creating synthetic, tailor-made materials that enhance the performance and sustainability of construction applications, including cement and concrete. By leveraging advanced knowledge in chemistry, material science, and nanotechnology, Nanogence has developed patented additive formulations that significantly improve the binding efficiency of cement and concrete while reducing carbon emissions by up to 50%. This enables manufacturers to achieve valuable cost savings, enhance durability, and contribute to more sustainable construction practices in a rapidly growing global market.

Nanogence SA, established in 2017 and located in Renens, Switzerland, specializes in the development of innovative material solutions for the construction industry. The company focuses on creating synthetic, tailor-made materials that enhance the performance and sustainability of construction applications, including cement and concrete. By leveraging advanced knowledge in chemistry, material science, and nanotechnology, Nanogence has developed patented additive formulations that significantly improve the binding efficiency of cement and concrete while reducing carbon emissions by up to 50%. This enables manufacturers to achieve valuable cost savings, enhance durability, and contribute to more sustainable construction practices in a rapidly growing global market.

Vatorex AG, founded in 2016 and based in Winterthur, Switzerland, specializes in developing electronic solutions for beekeeping, specifically targeting the varroa mite, a significant threat to honey bee health. The company offers a range of products, including the Varroa Solution, a heat treatment system that effectively eliminates varroa mites while preserving the bees. Additionally, Vatorex provides the Full Hive Kit, which enables real-time monitoring and data collection for hive management, and the Hive Manager mobile application, designed for organizing hive-related information. By focusing on hyperthermic treatment that exploits the different temperature tolerances of bees and mites, Vatorex aims to enhance the health and sustainability of bee populations. The company markets its innovative solutions online, contributing to modern beekeeping practices.

Seervision AG, a Swiss startup founded in 2016 and based in Zurich, specializes in developing innovative software for camera automation aimed at enhancing video production efficiency. Originally conceived at ETH Zurich to improve live lecture recordings, the company has evolved into a dynamic enterprise with over 30 employees. The Seervision Suite now automates workflows primarily for corporate studios, stage events, and educational spaces. By leveraging advanced video analysis algorithms and technologies such as motion control, computer vision, and machine learning, Seervision enables fully automated productions, including autonomous camera tracking and facial recognition. This integration simplifies live production workflows, making it easier for users to manage hybrid meeting experiences and other video production needs.

SwissDeCode is a company based in Renens, Switzerland, that specializes in food safety and compliance services for food manufacturers. Founded in 2016, the company provides rapid onsite DNA testing solutions that help ensure food is safe to eat. By offering plug-and-play systems, SwissDeCode enables production facilities to obtain food safety and quality certificates within the same work shift. This capability allows food producers to swiftly address contamination threats and convert them into sustainable opportunities. Additionally, SwissDeCode's services verify food authenticity, safety, and origin, empowering inspectors to make immediate decisions regarding food compliance.

EBAMed SA is a Swiss startup based in Geneva, established in 2018, that focuses on developing innovative medical technology for treating heart arrhythmias. The company is working on an ultrasound-based device designed to monitor heart motion and facilitate non-invasive ablation therapy using proton beams. This technology aims to provide a safe and effective alternative for patients by allowing real-time synchronization of proton therapy with heart movement. By integrating both hardware and software components, EBAMed's device enhances treatment capabilities for existing proton therapy centers, enabling them to offer advanced, non-invasive treatment options for cardiac patients in an outpatient setting.

EBAMed SA is a Swiss startup based in Geneva, established in 2018, that focuses on developing innovative medical technology for treating heart arrhythmias. The company is working on an ultrasound-based device designed to monitor heart motion and facilitate non-invasive ablation therapy using proton beams. This technology aims to provide a safe and effective alternative for patients by allowing real-time synchronization of proton therapy with heart movement. By integrating both hardware and software components, EBAMed's device enhances treatment capabilities for existing proton therapy centers, enabling them to offer advanced, non-invasive treatment options for cardiac patients in an outpatient setting.